Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1M Buy
8,336
+39
+0.5% +$4.5K 0.1% 60
2025
Q4
$873K Sell
8,297
-622
-7% -$58.4K 0.09% 63
2025
Q3
$749K Buy
8,919
+822
+10% +$67.7K 0.08% 71
2025
Q2
$641K Buy
8,097
+2,630
+48% +$209K 0.07% 98
2025
Q1
$491K Buy
5,467
+2,601
+91% +$243K 0.06% 108
2024
Q4
$285K Buy
2,866
+728
+34% +$75.1K 0.04% 165
2024
Q3
$243K Buy
2,138
+17
+0.8% +$2.02K 0.03% 143
2024
Q2
$263K Buy
+2,121
New +$273K 0.04% 110
2018
Q4
Sell
-3,715
Closed -$251K 91
2018
Q3
$251K Buy
+3,715
New +$237K 0.14% 36

Other funds holding MRK

SYM Financial Corp's MRK Position: Q1 2026 in Review

SYM Financial Corp increased its Merck (MRK) stake by 0.47% in Q1 2026, buying an estimated $4.5K and bringing the position to 8,336 shares worth $1M. The position accounts for 0.1% of the portfolio, ranked #60.

SYM Financial Corp first reported a position in MRK in Q3 2018 and has held it in 9 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • SYM Financial Corp held 8,336 shares of Merck worth $1M as of Q1 2026.
  • SYM Financial Corp bought 39 Merck shares in Q1 2026, an estimated $4.5K.
  • Merck made up 0.1% of SYM Financial Corp's portfolio in Q1 2026, its #60 holding.
  • SYM Financial Corp first reported a position in Merck in Q3 2018 and has held it in 9 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on SYM Financial Corp's 13F filing for Q1 2026, filed 8 May 2026.